| 标题 |
专利、报告等 Sacituzumab govitecan (SG) vs treatment of physician’s choice (TPC) in Chinese patients (pts) with hormone receptor-positive and human epidermal growth factor receptor 2-negative (HR+/HER2–) metastatic breast cancer (mBC): Sub analysis of the results from the phase III EVER-132-002 study
中国激素受体阳性和人表皮生长因子受体2阴性（HR+/HER2-）转移性乳腺癌（mBC）患者（PT）中Sacituzumab govitecan（SG）与医生选择治疗（TPC）的比较：III期EVER-132-002研究结果的子分析
|
| 网址 | |
| DOI |
暂未提供，该求助的时间将会延长，查看原因？
|
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
嘻嘻哈哈
OK
GingerF
AllRightReserved
cdercder
loii
Scorpia112
2226
YifanWang
wzhtnl
闪闪的忆枫
互助
张欢馨
jshmech
无极微光
汉堡包
许靓仔
潇洒的惋清
MchemG
贪玩的秋柔
皖公网安备34019202002308
